Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04945369

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Follow-up During the Peripubertal Period of Preterm Children (Under 35 Weeks of Amenorrhea) Included in the "EPIPOD" Protocol : Evaluation of Insulin Resistance

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
8 Years – 14 Years
Healthy volunteers
Not accepted

Summary

Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.

Conditions

Interventions

TypeNameDescription
OTHERclinical and biological measurements and questionnairesBlood and urinary samples collection for evaluation of insulin resistance and of renal function analysis. Assessment of body composition by BOP-POD and by impedancemetry. Assessment of pulse wave by popmetre. Assessment of physical activity by accelerometer and by questionnaire Questionnaires for analysis of eating behaviour

Timeline

Start date
2022-02-02
Primary completion
2028-02-02
Completion
2028-02-02
First posted
2021-06-30
Last updated
2025-11-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04945369. Inclusion in this directory is not an endorsement.